Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00503243
Status:
COMPLETED
Last Update Posted:
2021-06-11
First Post:
2007-07-16
Brief Title:
Safety and Efficacy of SPD476 Mesalazine Given Twice Daily 24 gDay vs SPD476 Given as a Single Dose 48 gDay in Subjects With Acute Mild to Moderate Ulcerative Colitis
Sponsor:
Organization:
Takeda
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
280
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: